Tan: Protocol says marketing surveillance should’ve been done for new drug like Dengvaxia
Quezon 4th District Representative Angelina Tan said marketing surveillance should have been conducted on the controversial Dengvaxia dengue vaccine since it is a new drug.
The Quezon politiko made the remark after the University of the Philippines-Philippine General Hospital (UP-PGH) said at least three deaths were connected to Dengvaxia.
“Yun din ang naging basehan kaya tinatanong din ng mga House Members, should it be enough para i-refund ang pera na binayad sa Dengvaxia?” Tan asked.
She said marketing surveillance of a new drug is basic protocol.
“Hindi lang deaths kundi lahat ng pwedeng mangyari sa isang pasyente dinu-dokumento. Katulad nitong Dengvaxia, may nakikita na tayong deaths. Katulad ng sabi ni Chairman Pimentel, pwede natin talagang sabihin failed talaga ung sa dengue immunization program, though ang argument nila palagi, there is no such vaccine na may 100% protection,” Tan said.#
Recommended on other sites
Politiko Main Latest News
North Luzon Latest News
Metro Manila Latest News
Central Luzon Latest News
Bicol Latest News
Visayas Latest News
The comments posted on this site do not necessarily represent or reflect the views of management and owner of POLITICS.com.ph. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.